This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Cell Cure Neurosciences Ltd. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Orit Gamburg: Innovator in Retinal Cell Therapy
Introduction
Orit Gamburg is a prominent inventor based in Modiin-Maccabim-Reut, Israel. She has made significant contributions to the field of retinal cell therapy, focusing on innovative solutions for retinal degenerative diseases.
Latest Patents
Orit Gamburg holds a patent for "Retinal pigment epithelium cell compositions." This patent presents ready-to-administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions aimed at treating retinal degenerative diseases and injuries. The patent details a method for formulating human RPE cells for administration directly after thawing, as well as for cryopreservation. Additionally, it describes a thaw and inject (TAI) composition, which allows for the administration of the composition by injection after thawing.
Career Highlights
Orit Gamburg is associated with Cell Cure Neurosciences Ltd., where she continues to advance her research and development in the field of retinal therapies. Her work is pivotal in addressing the challenges posed by retinal degenerative conditions.
Collaborations
Orit collaborates with Ofer Wiser, contributing to the innovative research environment at Cell Cure Neurosciences Ltd.
Conclusion
Orit Gamburg's work in retinal cell therapy exemplifies her commitment to advancing medical science and improving patient outcomes. Her innovative approaches and patented technologies are paving the way for new treatments in retinal health.